NPC remodeling drives #osteoclastogenesis by reshaping #chromatin architecture and epigenetic accessibility, with Nup133, Dnmt3a, and Ezh2 emerging as key regulators of #osteoclast differentiation and promising therapeutic targets for #BoneDiseases.

Read: doi.org/10.1016/j.ge...

An overview of the regulatory role of #m6Amodification in #BoneFormation & #StemCell directional differentiation, its pathological role & underlying mechanisms in #BoneDiseases, and m6A targeting therapeutic strategies.

#OpenAccess: doi.org/10.1016/j.ge...

AMP publishes!
"Bone Infarction of the Jaw with Regional Hematoma Collections: A Rare Complication in Sickle Cell Disease".

Full paper available at www.actamedicaportuguesa.com/revista/inde....

#anemia, #sicklecell #bonediseases #infarction #mandiblesis

PDRadiopharma’s Techne® Pyrophosphate Injection simplifies bone disease diagnostics! Approved in Japan for NHI listing and launching in February 2025. A big step for healthcare innovation!
#BoneHealth #HealthcareInnovation #MedicalBreakthrough #Diagnostics #Radiopharmaceuticals #BoneDiseases